however, because data showed that semaglutide was so clearly effective in improving heart failure and mortality outcomes in a high-risk population of people with type 2 diabetes and CKD, Ozempic was well-positioned to become a treatment option for heart failure, too
The FTCs Orange Book enforcement campaign has removed a significant automatic-stay mechanism from the patent defense toolkit
Legal and Ethical Considerations The FDA has issued statements warning against using semaglutide sodium salt due to lack of equivalence data
Whilst most patients experience weight reduction as a secondary benefit, some individuals report unexpected weight gain during treatment, which can be both frustrating and concerning
While Camilleri (2012) and Touny (2022) used prolonged monitoring periods of weeks or months to evaluate long-term effects, Hellstrm (2008) study had no follow-up following the treatment period
Cardiovascular and metabolic heterogeneity of obesity: clinical challenges and implications for Management
